title: Management of endometrial cancer.
abstract: Endometrial cancer is the fourth most common malignancy diagnosed in US women. Although most cases present in early stages and respond well to surgical staging with appropriately administered adjuvant radiation, the prognosis for advanced endometrial cancers is comparatively poor. Currently available treatments for advanced and recurrent metastatic endometrial cancer have significant toxicities, and are given to a population that is usually elderly with multiple other medical comorbidities. This article examines the pathogenesis of endometrial cancer as well as its diagnosis and management.
authors.affiliation: University of California Davis Medical Center, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, 4860 Y Street, Suite 2500, Sacramento, CA 95817, USA. wlfowler@ucdavis.edu
authors.forename: Wiley
authors.initials: W
authors.lastname: Fowler
authors.forename: David
authors.initials: D
authors.lastname: Mutch
mesh_terms: D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D016889:Endometrial Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012307:Risk Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D016387:Women's Health